These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33216994)

  • 1. The global burden of illness of peanut allergy: A comprehensive literature review.
    Lieberman JA; Gupta RS; Knibb RC; Haselkorn T; Tilles S; Mack DP; Pouessel G
    Allergy; 2021 May; 76(5):1367-1384. PubMed ID: 33216994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Peanut Allergy Diagnosis in a US Health Care Claims Database (2011-2017).
    Mahr TA; Lieberman JA; Haselkorn T; Damle V; Ali Y; Chidambaram A; Griffin NM; Sublett JW
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1683-1694.e5. PubMed ID: 33346150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peanut allergy impact on productivity and quality of life (PAPRIQUA): Caregiver-reported psychosocial impact of peanut allergy on children.
    Acaster S; Gallop K; de Vries J; Ryan R; Vereda A; Knibb RC
    Clin Exp Allergy; 2020 Nov; 50(11):1249-1257. PubMed ID: 32866989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APPEAL-1: A multiple-country European survey assessing the psychosocial impact of peanut allergy.
    DunnGalvin A; Blumchen K; Timmermans F; Regent L; Schnadt S; Podestà M; Sánchez A; Couratier P; Feeney M; Hjorth B; Patel R; Lush T; Ryan R; Vereda A; Fernández-Rivas M; Fisher HR
    Allergy; 2020 Nov; 75(11):2899-2908. PubMed ID: 32400915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APPEAL-1: A pan-European survey of patient/caregiver perceptions of peanut allergy management.
    Blumchen K; DunnGalvin A; Timmermans F; Regent L; Schnadt S; Podestà M; Sánchez A; Couratier P; Feeney M; Hjorth B; Patel R; Lush T; Ryan R; Vereda A; Fisher HR; Fernández-Rivas M
    Allergy; 2020 Nov; 75(11):2920-2935. PubMed ID: 32438514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Health and Economic Outcomes of Peanut Allergy Management Practices.
    Shaker M; Greenhawt M
    J Allergy Clin Immunol Pract; 2018; 6(6):2073-2080. PubMed ID: 29751153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current insights: a systemic review of therapeutic options for peanut allergy.
    O'Rourke E; Tang H; Chin A; Long A; Sindher S; Chinthrajah RS
    Curr Opin Allergy Clin Immunol; 2022 Jun; 22(3):188-193. PubMed ID: 35660711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doing More with Less.
    Lin AA; Fulkerson PC
    NEJM Evid; 2023 Nov; 2(11):EVIDe2300223. PubMed ID: 38320531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peanut allergy: Burden of illness.
    Shaker M; Greenhawt M
    Allergy Asthma Proc; 2019 Sep; 40(5):290-294. PubMed ID: 31514787
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of anaphylaxis and accidental peanut exposure: A systematic review.
    Muraro A; Sublett JW; Haselkorn T; Nilsson C; Casale TB
    Clin Transl Allergy; 2021 Oct; 11(8):e12064. PubMed ID: 34708943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peanut allergy.
    Lee CW; Sheffer AL
    Allergy Asthma Proc; 2003; 24(4):259-64. PubMed ID: 12974192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dendritic cells in peanut allergy.
    Aguilera-Insunza R; Venegas LF; Iruretagoyena M; Rojas L; Borzutzky A
    Expert Rev Clin Immunol; 2018 May; 14(5):367-378. PubMed ID: 29681186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APPEAL-2: A pan-European qualitative study to explore the burden of peanut-allergic children, teenagers and their caregivers.
    DunnGalvin A; Gallop K; Acaster S; Timmermans F; Regent L; Schnadt S; Podestà M; Sánchez A; Ryan R; Couratier P; Feeney M; Hjorth B; Fisher HR; Blumchen K; Vereda A; Fernández-Rivas M
    Clin Exp Allergy; 2020 Nov; 50(11):1238-1248. PubMed ID: 32757478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-care resource utilization associated with peanut allergy management under allergen avoidance among commercially insured individuals.
    Meadows JA; Yu S; Hass SL; Guerin A; Latremouille-Viau D; Tilles SA
    Allergy Asthma Proc; 2021 Jul; 42(4):333-342. PubMed ID: 34187625
    [No Abstract]   [Full Text] [Related]  

  • 15. The Cost-Effectiveness of Preschool Peanut Oral Immunotherapy in the Real-World Setting.
    Shaker M; Chan ES; Protudjer JLP; Soller L; Abrams EM; Greenhawt M
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2876-2884.e4. PubMed ID: 33744474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining Levers of Cost-effectiveness for Screening Infants at High Risk for Peanut Sensitization Before Early Peanut Introduction.
    Greenhawt M; Shaker M
    JAMA Netw Open; 2019 Dec; 2(12):e1918041. PubMed ID: 31860109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the impact of food allergy on anxiety and quality of life.
    Shaker MS; Schwartz J; Ferguson M
    Curr Opin Pediatr; 2017 Aug; 29(4):497-502. PubMed ID: 28509782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life after LEAP: How to implement advice on introducing peanuts in early infancy.
    Fleischer DM
    J Paediatr Child Health; 2017 Mar; 53(S1):3-9. PubMed ID: 28276109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peanut Allergy: New Advances and Ongoing Controversies.
    Abrams EM; Chan ES; Sicherer S
    Pediatrics; 2020 May; 145(5):. PubMed ID: 32303583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and characteristics of peanut allergy in US adults.
    Warren C; Lei D; Sicherer S; Schleimer R; Gupta R
    J Allergy Clin Immunol; 2021 Jun; 147(6):2263-2270.e5. PubMed ID: 33579526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.